OpenAI proposes handing Trump administration a 5% stake, FT reports OpenAI has discussed giving the U.S. government a 5% stake, the Financial Times reported on Thursday, as AI firms face scrutiny in ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results